Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 31-40 of 47 (Search time: 0.008 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Measuring the unbound concentration fails to resolve analytic interferences in digoxin immunoassaysMorris, R.; Jones, T.; Wicks, F.; Rogers, N.
2002Cyclosporin monitoring in Australasia: 2002 update of concensus guidelinesMorris, R.; Ilet, K.; Tett, S.; Ray, J.; Fullinfaw, R.; Cooke, R.; Cook, S.
2001Cyclosporin monitoring - state of the art?Morris, R.; Russ, G.
2005CEDIA├ĺ sirolimus assay compared with HPLC-MS/MS and HPLC-UV in transplant recipient specimensWestley, I.; Morris, R.; Taylor, P.; Salm, P.; James, M.
2002Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral®) at day 7 post-renal transplantation and incidence of rejection in the first monthMorris, R.; Russ, G.; Cervelli, M.; Juneja, R.; McDonald, S.; Mathew, T.
2006Role of MRP2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: Effect of cyclosporineWestley, I.; Brogan, L.; Morris, R.; Evans, A.; Sallustio, B.
2005Evaluation of the immunotech cyclosporine direct radioimmunoassay for the determination of whole-blood cyclosporine in renal transplant patientsWesley, I.; Sallustio, B.; Morris, R.
2005Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasmaWestley, I.; Sallustio, B.; Morris, R.
2004Determination of perhexiline and hydroxyperhexiline in plasma by liquid chromatography-mass spectrometryBeck, O.; Stephanson, N.; Morris, R.; Sallustio, B.; Hjemdahl, P.
2002Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state doseSallustio, B.; Westley, I.; Morris, R.